Press Releases from ChemImage Corporation (6 total)
ChemImage Reports Advances in Characterization of Untreated Fingerprints
PITTSBURGH, Dec. 8, 2010 — ChemImage Corporation recently reported results from a hyperspectral imaging (HSI) study that displayed a 42.8% overall improvement in characterization of latent fingerprints in comparison to previous HSI image processing methods.
Improved data collection and image processing techniques were used to examine aged and recently deposited latent fingerprints on various surfaces that typically prove to be more difficult for forensic scientists, including white lined paper,…
ChemImage Reaches Agreement with Light Ace HK LTD to Distribute the FALCON II Sy …
PITTSBURGH, Aug. 23, 2010 — ChemImage Corporation recently reached an agreement with Light Ace HK LTD, a China-based distributor of laboratory equipment, instrumentation and services, to offer the Falcon II Wide-Field Raman Chemical Imaging System and select analytical contract services in China.
“This agreement affirms the value chemical imaging can bring to the international marketplace,” said Jim McGlone, president at ChemImage. “We look forward to working with Light Ace to develop…
ChemImage to Present Inkjet Discrimination Research Results at the 6th EDEWG Con …
PITTSBURGH, Aug. 17, 2010 — ChemImage Corporation will be presenting research results on a new inkjet printer discrimination technique involving hyperspectral imaging (HSI) at the 6th EDEWG Conference, a meeting of the European Document Experts Working Group, in Dubrovnik, Croatia from Sept. 21-24.
A part of the European Network of Forensic Science Institutes (ENFSI), the European Document Experts Working Group supports ENFSI’s forensic document examination objectives. Held every two…
Prediction of Prostate Cancer Progression Possible with Hyperspectral Imaging
PITTSBURGH, Aug. 11, 2010 — A study conducted by scientists at ChemImage Corporation, in partnership with a well-known U.S. medical research and treatment center, revealed that Raman Molecular Imaging (RMI), a type of hyperspectral imaging, has potential in predicting the progression of prostate cancer.
Blinded samples from 38 patients with Gleason score 7 prostate cancer were evaluated using RMI, an emerging technology that combines digital imaging and molecular spectroscopy to analyze…
ChemImage to Participate in the 37th Annual Meeting and Exposition of the Contro …
PITTSBURGH, May 17, 2010 — ChemImage Corporation will be presenting and exhibiting at the 37th Annual Meeting and Exposition of the Controlled Release Society, an international gathering focused on the science and technologies behind the delivery of bioactive agents, July 10-14 at the Oregon Convention Center in Portland, Ore.
“We’re really looking forward to participating in this year’s meeting and sharing some relevant findings about Raman chemical imaging’s (RCI) ability to…
Research Points to Raman Chemical Imaging as Means for Determining Drug Particle …
PITTSBURGH, May 3, 2010 — Recent research conducted by scientists at ChemImage Corporation revealed that wide-field Raman Chemical Imaging (RCI) shows promise as an in vitro method for identifying drug particle size distribution of Advair Discus® 500/50, a commercial dry powder inhaler with two active pharmaceutical ingredients.
A dry powder inhaler delivers medication directly to the lungs, so the understanding of its particle size distribution specific to each ingredient is important…
